Metraipolis › archive › dc_2be4be6d0653

FACIT-fatigue score and treatment quality assessment for paroxysmal nocturnal hemoglobinuria patients treated with Eculizumab in Türkiye — Europe PMC PMID:42726724

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42726724
DOI
10.1371/journal.pone.0355720
License (as archived)
solo-consultazione
Archived
2026-10-15T16:34:24.319Z
SHA-256 of the archived text
95a37067ea1e11920460177ce97d3969017fce607eab07679e99a59416823ae2
Stable URL of this page
https://metraipolis.com/documento/dc_2be4be6d0653

How to cite

FACIT-fatigue score and treatment quality assessment for paroxysmal nocturnal hemoglobinuria patients treated with Eculizumab in Türkiye — Europe PMC PMID:42726724 — Europe PMC (en), https://europepmc.org/article/MED/42726724 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2be4be6d0653 (Metraipolis archive dc_2be4be6d0653, sha256 95a37067ea1e11920460177ce97d3969017fce607eab07679e99a59416823ae2)
BibTeX
@misc{dc2be4be6d0653,
  title = {FACIT-fatigue score and treatment quality assessment for paroxysmal nocturnal hemoglobinuria patients treated with Eculizumab in Türkiye — Europe PMC PMID:42726724},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42726724},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2be4be6d0653; sha256 95a37067ea1e11920460177ce97d3969017fce607eab07679e99a59416823ae2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42726724. Agents can read the archived copy with the MCP tool read_document.